https://www.selleckchem.com/pr....oducts/ins018-055-is
The risk of developing TB in patients with over 20 average defined daily doses (DDDs) per year was increased by 2.19 times (P=0.048). In our long-term nationwide population-based cohort study, higher doses of DPP4i (20 average DDDs) could increase TB infection risk in patients with diabetes. To pay more attention to this kind of diabetic patients with DPP4i treatment will be more important for the public health issue of TB prevention. In our long-term nationwide population-based cohort study, higher doses of DPP4i (20 aver
Like
Comment
Share
